Approval · Notice of Compliance 2299 · 2001
LOPID: Notice of Compliance 2299
Issued January 17, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2299
- Date
- January 17, 2001
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antihyperlipidemic agent
Products in this notice
Medicinal ingredients
- GEMFIBROZIL 300 MG per CAP
- GEMFIBROZIL 600 MG per TAB